Pune, India -- (SBWire) -- 11/02/2018 --Industry trends:
Blood being the fluid flowing through the body, it has become vital to test its condition for anemia, blood count and many other tests such as cholesterol and triglycerides to aid in assessment of presence or risk of heart disease. Hematology analyzers and reagents are used to conduct a number of coagulation tests by integrating the adoption of machine-driven hematology instruments. Rising innovation in the field of pharmacogenomics, bleeding disorders, stem cell therapy, genomes and proteomics are propelling the hematology analyzers and reagents market. However, the lack of skilled professionals to carry out these tests is hampering the market's growth. The growing prevalence of blood related disorders such as sickle cell sickness, bone marrow disorders, anemia and chronic lead poisoning is expected to drive the market in the future.
For Sample Copy of this Report : https://www.healthcareintelligencemarkets.com/request_sample.php?id=29003
Global hematology analyzers and reagents market was valued at US$ XXXX XX in XXXX and is anticipated to reach US$ XXXX XX by XXXX.
Hematology Analyzers and Reagents Market, by Application
Blood disorders like anemia and other hemorrhage conditions have led to a rising significance of the importance of hematology across medical disciplinarians. Rapid technological advancements and the rising occurrence of blood related diseases is the driving the growth of the market.
Avail Discount on this report : https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=29003
Competitive Landscape:
Hematology Analyzers and Reagents Market report provides both, qualitative and quantitative research of the market, as well as provides worthy insights into the rational scenario and favored development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarter, competitors, product/service type, application and specification, pricing, and gross margin.
The primary market participants include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Agilent Technologies Inc., Dolomite Centre, F. Hoffmann-La Roche Fluidigm Corporation, Micronit Microfluidics BV, AG, PerkinElmer Inc., Thermo Fisher Scientific Inc., and uFluidix, among others.
